Information
-
Trademark
-
97844217
-
Serial Number
97844217
-
Registration Number
7635115
-
International Classifications
-
Filing Date
March 17, 2023
3 years ago
-
Registration Date
December 31, 2024
a year ago
-
Transaction Date
December 31, 2024
a year ago
-
Status Date
December 31, 2024
a year ago
-
Published for Opposition Date
January 30, 2024
2 years ago
-
Location Date
December 09, 2024
a year ago
-
First Use Anywhere Date
May 12, 2021
5 years ago
-
First Use In Commerce Date
May 12, 2021
5 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
STOIDES, KATHERINE
-
Attorney Docket Number
16187.0007
Attorney Name
Danny M. Awdeh
Law Office Assigned Location Code
L10
-
Owners
Mark Drawing Code
4
Mark Identification
CRINETICS
Case File Statements
- GS0051: Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine related diseases; pharmaceutical preparations for targeting neuropeptide receptors; pharmaceutical preparations for the treatment of cancer, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, carcinoid syndrome, congenital adrenal hyperplasia, hypercalcemia, chronic pain, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic preparations for the treatment of ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders
- GS0421: Medical research services; scientific research and development; pharmaceutical research and development; therapeutic research and development, namely, research and development of therapeutic preparations; research and development in the field of oncology; medical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; pharmaceutical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic research, namely, research of therapeutic preparations for ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and therapeutics
Case File Event Statements
-
3/21/2023 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/9/2023 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
10/9/2023 - 2 years ago
3 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
10/9/2023 - 2 years ago
10 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
12/13/2023 - 2 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/18/2023 - 2 years ago
5 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
12/18/2023 - 2 years ago
6 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
12/18/2023 - 2 years ago
7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
12/19/2023 - 2 years ago
8 - ASSIGNED TO LIE
Type: ALIE
-
12/19/2023 - 2 years ago
9 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
12/22/2023 - 2 years ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
1/10/2024 - 2 years ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
1/30/2024 - 2 years ago
13 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
1/30/2024 - 2 years ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
2/28/2024 - 2 years ago
15 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
2/28/2024 - 2 years ago
16 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
2/28/2024 - 2 years ago
17 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
3/26/2024 - 2 years ago
18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
9/12/2024 - a year ago
25 - USE AMENDMENT FILED
Type: IUAF
-
9/12/2024 - a year ago
23 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
9/12/2024 - a year ago
19 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
9/12/2024 - a year ago
22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
9/12/2024 - a year ago
20 - SOU EXTENSION 1 FILED
Type: EXT1
-
9/12/2024 - a year ago
21 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
11/13/2024 - a year ago
24 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
11/14/2024 - a year ago
26 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
12/9/2024 - a year ago
27 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
12/9/2024 - a year ago
28 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
12/31/2024 - a year ago
29 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
12/31/2024 - a year ago
30 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
